Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-Aβ15-42, ACC-001 Vector   (CAT#: GTVCR-WQ250MR)

This product GTVCR-WQ250MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting Aβ15-42. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Corynebacterium diphtheriae; Homo sapiens
RefSeq NM_000484.4
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 351
UniProt ID P05067
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-Aβ15-42, ACC-001 Vector (GTVCR-WQ250MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ2056MR IVTScrip™ pT7-VEE-mRNA-Anti-CD274, MSB-0010718C Vector Vector MSB-0010718C
GTVCR-WQ2359MR IVTScrip™ pT7-VEE-mRNA-Anti-NGF, aNGF75 Vector Vector aNGF75
GTVCR-WQ1187MR IVTScrip™ pT7-VEE-mRNA-Anti-FAP, FAP-IL2v Vector Vector FAP-IL2v
GTVCR-WQ1574MR IVTScrip™ pT7-VEE-mRNA-Anti-IL2R, Interleukin 2 Vector Vector Interleukin 2
GTVCR-WQ903MR IVTScrip™ pT7-VEE-mRNA-Anti-env, CD4(178) PE40 Vector Vector CD4(178) PE40
GTVCR-WQ1907MR IVTScrip™ pT7-VEE-mRNA-Anti-PDGFRA, MEDI-575 Vector Vector MEDI-575
GTVCR-WQ655MR IVTScrip™ pT7-VEE-mRNA-Anti-PDCD1, BCD-100 Vector Vector BCD-100
GTVCR-WQ151MR IVTScrip™ pT7-VEE-mRNA-Anti-PRLR, ABBV-176 Vector Vector ABBV-176
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.